{"title":"Medium- to Long-Term Follow-Up Study on Modified Manchester Procedure for Pelvic Organ Prolapse.","authors":"Yan Chen, Shuqiong Xu, Na Luo, Lingying Du","doi":"10.1007/s00192-025-06237-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and hypothesis: </strong>We evaluated the complications and medium- to long-term therapeutic outcomes of the modified Manchester procedure for pelvic organ prolapse.</p><p><strong>Methods: </strong>The clinical data of 254 patients who underwent the modified Manchester procedure in our hospital from July 2015 to May 2023 were retrospectively analyzed. In addition, the perioperative situation and medium- to long-term follow-up results were analyzed.</p><p><strong>Results: </strong>No injury to the adjacent organs (such as the bladder and ureter) or complications (including massive hemorrhage or hematoma) were reported in 254 patients during the operation. During the perioperative period, urinary retention, postoperative fever, and urinary tract infections were observed in 19 patients (7.5%), 13 patients (5.1%), and three patients (1.2%), respectively. Follow-up ranged from 1 to 8.8 years, with a median follow-up time of 4.18 (2.46, 6.15) years, and 173 patients (68%) completed telephonic or outpatient follow-up. Among them, 16 patients (9.25%) had subjective recurrence. Of these 16 patients, three (1.7%) had failed surgery, nine (5.2%) had de novo stress urinary incontinence, and two (1.2%) had dysuria. The most serious complications were grade III according to the Clavien-Dindo classification. After the operation, the subjective satisfaction rate of the PGI-I questionnaire was 94.8%.</p><p><strong>Conclusions: </strong>The modified Manchester procedure for pelvic organ prolapse has a low incidence of severe complications, has satisfactory medium- to long-term therapeutic outcomes, and shows favorable safety and efficacy.</p>","PeriodicalId":14355,"journal":{"name":"International Urogynecology Journal","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urogynecology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00192-025-06237-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and hypothesis: We evaluated the complications and medium- to long-term therapeutic outcomes of the modified Manchester procedure for pelvic organ prolapse.
Methods: The clinical data of 254 patients who underwent the modified Manchester procedure in our hospital from July 2015 to May 2023 were retrospectively analyzed. In addition, the perioperative situation and medium- to long-term follow-up results were analyzed.
Results: No injury to the adjacent organs (such as the bladder and ureter) or complications (including massive hemorrhage or hematoma) were reported in 254 patients during the operation. During the perioperative period, urinary retention, postoperative fever, and urinary tract infections were observed in 19 patients (7.5%), 13 patients (5.1%), and three patients (1.2%), respectively. Follow-up ranged from 1 to 8.8 years, with a median follow-up time of 4.18 (2.46, 6.15) years, and 173 patients (68%) completed telephonic or outpatient follow-up. Among them, 16 patients (9.25%) had subjective recurrence. Of these 16 patients, three (1.7%) had failed surgery, nine (5.2%) had de novo stress urinary incontinence, and two (1.2%) had dysuria. The most serious complications were grade III according to the Clavien-Dindo classification. After the operation, the subjective satisfaction rate of the PGI-I questionnaire was 94.8%.
Conclusions: The modified Manchester procedure for pelvic organ prolapse has a low incidence of severe complications, has satisfactory medium- to long-term therapeutic outcomes, and shows favorable safety and efficacy.
期刊介绍:
The International Urogynecology Journal is the official journal of the International Urogynecological Association (IUGA).The International Urogynecology Journal has evolved in response to a perceived need amongst the clinicians, scientists, and researchers active in the field of urogynecology and pelvic floor disorders. Gynecologists, urologists, physiotherapists, nurses and basic scientists require regular means of communication within this field of pelvic floor dysfunction to express new ideas and research, and to review clinical practice in the diagnosis and treatment of women with disorders of the pelvic floor. This Journal has adopted the peer review process for all original contributions and will maintain high standards with regard to the research published therein. The clinical approach to urogynecology and pelvic floor disorders will be emphasized with each issue containing clinically relevant material that will be immediately applicable for clinical medicine. This publication covers all aspects of the field in an interdisciplinary fashion